The bright orange UT logo unveiled Wednesday, Feb. 25, on exterior signage at the largest and most comprehensive hospital in the Methodist Le Bonheur Healthcare system is a striking symbol of a successful partnership that started more than a decade ago and continues to grow.
Monica Brown, DO, and her team are researching the effects of a natural form of Vitamin D on scleroderma. Scleroderma is a disease characterized by hardening of the skin and organs due to collagen overproduction and a lack of enzymes to break collagen down. One of the reasons too much collagen is produced has to… Read More
Beginning this week, the University of Tennessee initials will appear on a Memphis hospital for the first time since 2004, when the UT Bowld Hospital closed its doors.
Medicare penalties implemented in 2008 have made a difference in reducing certain hospital-acquired complications, according to a paper authored by Teresa M. Waters, PhD, chair of the Department of Preventive Medicine in the College of Medicine at the University of Tennessee Health Science Center (UTHSC).
Osteoarthritis (OA) is an increasingly large burden on the American health care system. This debilitating condition affects 60 percent of Americans over the age of 60 — the fastest-growing demographic in the nation.
Significant eye injuries are common in the military personnel who served in Iraq and Afghanistan. Edward Chaum, MD, PhD, Plough Professor of Retinal Diseases at the University of Tennessee Health Science Center (UTHSC), has received a grant totaling $999,488 from the U.S. Army Medical Research Acquisition Activity to study the effects of ocular trauma.
The West Tennessee Regional Forensic Center (WTRFC), which is managed by the University of Tennessee Health Science Center (UTHSC), is one of four Tennessee locations participating in the new Sudden Death in the Young (SDY) Case Registry, a national data collection project to learn more about the reasons for sudden and unexplained deaths of those… Read More
Ryan Yates, PharmD, PhD, professor in the Department of Pharmaceutical Sciences at the University of Tennessee Health Science Center (UTHSC), is the recipient of a $15,000 award from the University of Tennessee Research Foundation. The award will support a project titled, “Pre-clinical ADMET of JP-153: A Treatment for Retinal Neovascularization.” Diabetic retinopathy and age-related macular… Read More
